Atmo Biosciences is a company founded in 2012 by Malcolm Hebblewhite.
Atmo is a clinical stage digital health business focused on empowering researchers, clinicians and patients with objective real-time insights into gut health and microbiome function.
Atmo is a clinical stage digital health business focused on empowering researchers, clinicians and patients with objective real-time insights into gut health and microbiome function.